Custom Lipid Nanoparticle Delivery Systems for Pharma & Biotech

DIVERSA Technologies designs and develops proprietary lipid nanoparticle delivery systems tailored to your therapeutic molecules. We partner with pharma and biotech companies to solve the delivery challenges of complex payloads, including mRNA, siRNA and pDNA/cDNA (up to 12 Kb), monoclonal antibodies, proteins (up to 540 kDa), peptides, small molecules, and natural extracts.

Our platforms achieve >90% encapsulation efficiency across diverse actives and have demonstrated up to 28X higher in vitro and 567X higher in vivo delivery efficiency compared to standard systems, ensuring superior expression and therapeutic outcomes. Additionally, our technology can extend the half-life of therapeutics by over 26-fold, reducing dosing frequency and improving patient compliance. All of this is supported by robust IP, securing freedom-to-operate (FTO) and minimizing regulatory hurdles.

Key benefits for pharma & biotech include:

• Scalability: Smooth transition from lab-scale to GMP manufacturing with consistent quality.

• Precision targeting: Directs payloads to specific tissues or cells, maximizing efficacy and minimizing off-target effects.

• Enhanced bioavailability: Improves cellular uptake and maintains therapeutic levels over extended periods.

• Stability: Protects sensitive molecules under physiological and storage conditions, preserving bioactivity.

• Versatility: Supports single or combined payloads, enabling advanced therapies from gene editing to novel biologics.

• PEG-free options: We offer PEG-free formulations to address regulatory or immunogenicity concerns, expanding compatibility and safety.

By leveraging our patented platforms and extensive formulation expertise, DIVERSA accelerates your therapeutics from bench to clinic, driving innovation with reduced risk and faster development timelines.